Case #1 shows the same KRAS and TP53 mutations between the primary tumor and the recurrence, and case #6 has the same KRAS G12R mutation in the primary and in both metachronous pancreatic ductal adenocarcinomas. The gene discussed is TP53; the disease is pancreatic ductal adenocarcinoma.